Watchlist Price Alert

OnKure Therapeutics Inc. (OKUR)

NASDAQ: OKUR · Real-Time Price · USD

2.46

-0.14 (-5.38%)

At close: Jun 17, 2025, 3:59 PM

OnKure Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Net Income	-15.93M	-35.19M	6.2M	-14.14M	-9.54M	18.52M	-36.97M	-8.18M	-8.68M
Depreciation & Amortization	212K	622K	-259K	148K	151K	434K	-157K	155K	128K
Stock-Based Compensation	2.75M	1.64M	973K	1.81M	107K	-3.59M	3.76M	17K	15K
Other Working Capital	641K	9.86M	-18.16M	5.7M	-1.35M	-8.13M	7.24M	-3.08M	3.98M
Other Non-Cash Items	n/a	2.06M	-1.75M	1K	n/a	2.15M	-2.15M	1K	-1K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.04M	9.86M	-18.16M	5.7M	-1.35M	-8.13M	7.24M	-3.08M	3.98M
Operating Cash Flow	-14.01M	-21.02M	-13M	-6.47M	-10.63M	9.38M	-28.28M	-11.09M	-4.55M
Capital Expenditures	-18K	-50K	17K	-10K	-9K	-50K	-125K	-60K	-11K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	-113.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	67.75M	61.25M	n/a	n/a	29.06M	-29.06M	n/a	n/a
Investing Cash Flow	-18K	-45.38M	61.27M	-10K	-9K	29.01M	-29.18M	-60K	-11K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-77K	55.31M	-3.95M	5.86M	n/a	53.06M	-53.06M	-8K	-716K
Financial Cash Flow	-77K	114.22M	-3.97M	5.87M	10K	-11.87M	11.89M	-2K	53.11M
Net Cash Flow	-14.1M	50.07M	42.06M	-615K	-10.63M	18.14M	-37.2M	-11.15M	48.54M
Free Cash Flow	-14.02M	-21.07M	-12.98M	-6.48M	-10.64M	9.33M	-28.41M	-11.15M	-4.56M